검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-12 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | AutoCD6-CAR Treg cells (AutoCD6-CAR Treg cells) City of Hope Medical Center·Stage 3 Type 1 Diabetes 1 trials |
|---|---|
Overview Program | AutoCD6-CAR Treg cells |
Overview Company | City of Hope Medical Center |
Overview Modality | CGT |
Overview Target | Stage 3 Type 1 Diabetes |
Overview Indication | Stage 3 Type 1 Diabetes |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
MoA Mechanism | checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) is an immune-related adverse event (irAE) follo |
MoA Biomarker | biomarker |
PK/PD Species | Mouse, In vivo |
PK/PD Animal (cat.) | Mouse, In vitro |
PK/PD Experiment | PD |
Toxicology Species | Mouse, In vivo |
Toxicology Animal (cat.) | Mouse, In vitro |
Toxicology Major finding | Therapeutic Potential of Ziyuglycosides from Sanguisorba officinalis : Anticancer and Immunomodulatory Properties.. Cancer represents a major global health threat, and the development of effective anticancer therapies is urgently needed. Sanguisorba officinalis (DY), a traditional Chinese herbal medicine, possesses properties including cooling blood and promoting blood circulation, detoxifying pat… |
Toxicology CRS | Reported |
Clinical Data Tier / Score | A · 9 |
Clinical Program phase | PHASE_1 |
Clinical Clinical sync | 2026년 7월 13일 (2일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-12 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | AutoCD6-CAR Treg cells (AutoCD6-CAR Treg cells) City of Hope Medical Center·Stage 3 Type 1 Diabetes 1 trials |
|---|---|
Overview Program | AutoCD6-CAR Treg cells |
Overview Company | City of Hope Medical Center |
Overview Modality | CGT |
Overview Target | Stage 3 Type 1 Diabetes |
Overview Indication | Stage 3 Type 1 Diabetes |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
MoA Mechanism | checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) is an immune-related adverse event (irAE) follo |
MoA Biomarker | biomarker |
PK/PD Species | Mouse, In vivo |
PK/PD Animal (cat.) | Mouse, In vitro |
PK/PD Experiment | PD |
Toxicology Species | Mouse, In vivo |
Toxicology Animal (cat.) | Mouse, In vitro |
Toxicology Major finding | Therapeutic Potential of Ziyuglycosides from Sanguisorba officinalis : Anticancer and Immunomodulatory Properties.. Cancer represents a major global health threat, and the development of effective anticancer therapies is urgently needed. Sanguisorba officinalis (DY), a traditional Chinese herbal medicine, possesses properties including cooling blood and promoting blood circulation, detoxifying pat… |
Toxicology CRS | Reported |
Clinical Data Tier / Score | A · 9 |
Clinical Program phase | PHASE_1 |
Clinical Clinical sync | 2026년 7월 13일 (2일 전) |
추천 비교
추천 비교